Clinical significance of maternal serum vascular endothelial growth factor (VEGF) level in idiopathic recurrent pregnancy loss

dc.contributor.authorUǧurlu, Nil
dc.contributor.authorZülfikaroǧlu, Ebru
dc.contributor.authorDanışman, Nuri
dc.contributor.buuauthorAtalay, Mehmet Aral
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı.tr_TR
dc.contributor.scopusid53863297800tr_TR
dc.date.accessioned2023-03-07T07:20:18Z
dc.date.available2023-03-07T07:20:18Z
dc.date.issued2016-07
dc.description.abstractOBJECTIVE: The aim of this study was to determine whether maternal serum vascular endothelial growth factor (VEGF) levels are associated with unexplained recurrent pregnancy losses (RPLs). PATIENTS AND METHODS: Twenty-one pregnant women with idiopathic RPLs who were selected from 47 cases with RPLs were compared with age-matched 24 control participants. Transvaginal obstetric ultrasonographies were performed and maternal serum samples were collected between 5th and 10th gestational weeks to evaluate serum VEGF and progesterone (P4) concentrations. Enzyme-linked immunosorbent assay technique was used in measurements of VEGF and P4. RESULTS: Prevalence of idiopathic cases among all RPLs was 44.7%. Median serum VEGF value was found statistically higher in RPL group when compared to control group (210.33 +/- 108.23 pg/ml vs. 123.91 +/- 18.8 pg/ml, respectively). There was no statistical difference between the median values of serum P4 levels in idiopathic RPL group and the control group (19.53 +/- 5.79 ng/ml and 20.08 +/- 7.85 ng/ml, respectively). Serum VEGF levels did not differ significantly with regard to gestational age within the RPL and control groups (p = 0.72 and p = 0.89, respectively). A positive correlation was found between VEGF levels and the patients' age within RPL group (r = 0.515). CONCLUSIONS: Serum VEGF levels are independent by the gestational age. Serum VEGF concentrations correlate positively to maternal age. Increased maternal age, especially maternal age over 35 years, is related to elevated serum VEGF concentration. Increased maternal serum VEGF concentration is related with recurrent pregnancy loss.tr_TR
dc.identifier.citationAtalay, M. A. vd. (2016). "Clinical significance of maternal serum vascular endothelial growth factor (VEGF) level in idiopathic recurrent pregnancy loss". European Review for Medical and Pharmacological Sciences, 20(14), 2974-2982.tr_TR
dc.identifier.endpage2982tr_TR
dc.identifier.issn1128-3602
dc.identifier.issue14tr_TR
dc.identifier.pubmed27460722tr_TR
dc.identifier.scopus2-s2.0-85016317094tr_TR
dc.identifier.startpage2974tr_TR
dc.identifier.urihttps://www.europeanreview.org/article/11164
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/27460722/
dc.identifier.urihttp://hdl.handle.net/11452/31387
dc.identifier.volume20tr_TR
dc.identifier.wos000382460900004
dc.indexed.pubmedPubMedtr_TR
dc.language.isoentr_TR
dc.publisherVerduci Publishertr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalEuropean Review for Medical and Pharmacological Sciencestr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccesstr_TR
dc.subjectPharmacology & pharmacytr_TR
dc.subjectVascular endothelial growth factortr_TR
dc.subjectProgesteronetr_TR
dc.subjectRecurrent pregnancy losstr_TR
dc.subjectRecurrent miscarriagetr_TR
dc.subjectMiscarriagetr_TR
dc.subjectWomentr_TR
dc.subjectProgesteronetr_TR
dc.subjectGenestr_TR
dc.subjectReceptortr_TR
dc.subjectFetaltr_TR
dc.subject.emtreeProgesteronetr_TR
dc.subject.emtreeVasculotropintr_TR
dc.subject.emtreeProgesteronetr_TR
dc.subject.emtreeVasculotropin Atr_TR
dc.subject.emtreeVEGFA protein, humantr_TR
dc.subject.emtreeAdulttr_TR
dc.subject.emtreeArticletr_TR
dc.subject.emtreeBlood leveltr_TR
dc.subject.emtreeBlood samplingtr_TR
dc.subject.emtreeClinical articletr_TR
dc.subject.emtreeControlled studytr_TR
dc.subject.emtreeCorrelation analysistr_TR
dc.subject.emtreeDisease associationtr_TR
dc.subject.emtreeEnzyme linked immunosorbent assaytr_TR
dc.subject.emtreeFemaletr_TR
dc.subject.emtreeGestational agetr_TR
dc.subject.emtreeHumantr_TR
dc.subject.emtreeMaternal agetr_TR
dc.subject.emtreeMaternal bloodtr_TR
dc.subject.emtreePregnancytr_TR
dc.subject.emtreePrevalencetr_TR
dc.subject.emtreeProgesterone blood leveltr_TR
dc.subject.emtreeRecurrent abortiontr_TR
dc.subject.emtreeTransvaginal echographytr_TR
dc.subject.emtreeBloodtr_TR
dc.subject.emtreeGestational agetr_TR
dc.subject.meshEnzyme-linked immunosorbent assaytr_TR
dc.subject.meshFemaletr_TR
dc.subject.meshGestational agetr_TR
dc.subject.meshHumanstr_TR
dc.subject.meshMaternal agetr_TR
dc.subject.meshPregnancytr_TR
dc.subject.meshProgesteronetr_TR
dc.subject.meshVascular endothelial growth factor Atr_TR
dc.subject.scopusVascular Endothelial Growth Factor A; Gene; Polymorphismtr_TR
dc.subject.wosPharmacology & pharmacytr_TR
dc.titleClinical significance of maternal serum vascular endothelial growth factor (VEGF) level in idiopathic recurrent pregnancy losstr_TR
dc.typeArticle

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections